- Company Details
TP-0413 is a novel small molecule inhibitor of the BMP pathway that has significant potential to be developed to treat anemia of cancer. Anemia of cancer is cytokine driven and results in the up-regul ...SBIRPhase I2012Department of Health and Human Services
TOLERO PHARMACEUTICALS, INC.
Lehi, UT, 84043
|# of Employees:||20|
|Socially and Economically Disadvantaged:||N|